Abstract:Although many genetic variants related to anti-tuberculosis drug induced liver injury (ATDILI) have been identified, the prediction and personalized treatment of ATDILI have failed to achieve, indicating there remains an area for further exploration. This study aimed to explore the influence of single nucleotide polymorphisms (SNPs) in Bradykinin receptor B2 (BDKRB2), Teneurin transmembrane protein 2 (TENM2), transforming growth factor beta 2 (TGFB2), and solute carrier family 2 member 13 (SLC2A13) on the risk of ATDILI. The subjects comprised 746 Chinese tuberculosis (TB) patients. Custom-by-design 2x48-Plex SNPscanTM kit was employed to genotype 28 selected SNPs. The associations of SNPs with ATDILI risk and clinical phenotypes were analyzed according to the distributions of allelic and genotypic frequencies and different genetic models. The odds ratio (OR) with corresponding 95% confidence interval (CI) was calculated. Among subjects with successfully genotyped, 107 participants suffered from ATDILI during follow-up. In BDKRB2, patients with rs79280755 G allele or rs117806152 C allele were more vulnerable to ATDILI (P-Bonferronicorrection=.002 and .03, respectively). Rs79280755 increased the risk of ATDILI significantly whether in additive (OR=3.218, 95% CI: 1.686-6.139, P-Bonferroni correction=.003) or dominant model (P-Bonferroni correction=.003), as well as rs117806152 (Additive model: P-Bonferroni (correction)=.05; dominant model: P-Bonferroni correction=.03). For TENM2, rs80003210 G allele contributed to the decreased risk of ATDILI (P-Bonferroni correction=.02), while rs2617972 A allele conferred susceptibility to ATDILI (P-Bonferroni correction=.01). Regarding rs2617972, significant findings were also observed in both additive (OR=3.203, 95% CI: 1.487-6.896, P-Bonferroni correction=.02) and dominant model (P-Bonferroni correction=.02). Moreover, rs79280755 and rs117806152 in BDKRB2 significantly affected some laboratory indicators. However, no meaningful SNPs were observed in TGFB2 and SLC2A13. Our study revealed that both BDKRB2 and TENM2 genetic polymorphisms were interrogated in relation to ATDILI susceptibility and some laboratory indicators in the Western Chinese Han population, shedding a new light on exploring novel biomarkers and targets for ATDILI.

Influence of HNF4α and HNF4α-AS1 Gene Variants on the Risk of Anti-Tuberculosis Drugs-Induced Hepatotoxicity

Genetic Polymorphisms of Xrcc1 Gene and Susceptibility to Hepatocellular Carcinoma in Chinese Population

Prospective Study Of Aldh1a1 Gene Polymorphisms Associated With Antituberculosis Drug-Induced Liver Injury In Western Chinese Han Population

Association of ABCC Gene Polymorphism with Susceptibility to Antituberculosis Drug–Induced Hepatotoxicity in Western Han Patients with Tuberculosis

Genetic Polymorphisms of Delta-Like 1 Homolog Influence the Susceptibility to Antituberculosis Drug-Induced Hepatotoxicity.

Analysis of IL-6, STAT3 and HSPA1L gene polymorphisms in anti-tuberculosis drug-induced hepatitis in a nested case-control study.

[Association of Rs1495741 Single Nucleotide Polymorphism with Susceptibility of Anti-tuberculosis Drug-induced Hepatotoxicity].

Association of PXR and CAR Polymorphisms and Antituberculosis Drug-Induced Hepatotoxicity

The genetic variants in calcium signaling related genes influence anti-tuberculosis drug induced liver injury: A prospective study.

Cytochrome P450 2e1 Gene Polymorphisms/Haplotypes And Anti-Tuberculosis Drug-Induced Hepatitis In A Chinese Cohort

Lack of association between genetic polymorphisms of CYP3A4, CYP2C9 and CYP2C19 and antituberculosis drug-induced liver injury in a community-based Chinese population.

Association of polymorphisms in drug transporter genes (SLCO1B1 and SLC10A1) and anti-tuberculosis drug-induced hepatotoxicity in a Chinese cohort

The Variant at TGFBRAP1 but Not TGFBR2 is Associated with Antituberculosis Drug-Induced Liver Injury

Study on Hereditary Susceptibility Genetic Markers to Anti-Tuberculosis Drug Induced Liver Injury in Chinese Population

Interleukin-4 and interleukin-10 polymorphisms and antituberculosis drug-induced hepatotoxicity in Chinese population.

CYP7A1, BAAT and UGT1A1 Polymorphisms and Susceptibility to Anti-Tuberculosis Drug-Induced Hepatotoxicity.

CYP2E1,GSTM1andGSTT1genetic Polymorphisms and Susceptibility to Antituberculosis Drug-Induced Hepatotoxicity: a Nested Case-Control Study

Association of CYP2B6 Gene Polymorphisms and Anti-Tuberculosis Drug-Induced Hepatotoxicity in a Chinese Population.

Genetic and Functional Evaluation of the Role of FOXO1 in Antituberculosis Drug-Induced Hepatotoxicity

Rs1800796 of the IL6 Gene is Associated with Increased Risk for Anti-Tuberculosis Drug-Induced Hepatotoxicity in Chinese Han Children.

NAT2 genetic polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in Chinese community population.